The Clinical Times
The Front Page of Medicine

Latest medical news · page 41

The latest headlines across every section, pulled from official and open-access sources.

JAMA Network Open · Jun 5, 2026

Patient Experiences With GLP-1 Receptor Agonists

This qualitative study involves thematic analyses of semistructured interviews on the experiences of adults currently or previously taking glucagon-like peptide-1 (GLP-1) receptor agonists in a variety of health contexts not limited to type 2 diabetes.

JAMA Network Open · Jun 5, 2026

Surgeon Perceptions of Failure to Rescue After Surgery

This qualitative study reports surgeon perspectives on patient death following a potentially manageable surgical complication, or failure to rescue, and identifies insights that may inform improvements in surgical education and culture.

JAMA Network Open · Jun 5, 2026

A Multiregional Decentralized Clinical Trial Program to Improve Access

This quality improvement study examines changes in the percentage of clinical trial participants who belong to underrepresented populations or live more than 120 miles away from an academic medical center after the implementation of a decentralized clinical trial program.

MedCity News · Jun 4, 2026

What the ‘One Nation, Overcharged’ Campaign Aims to Achieve

One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs. The post What the ‘One Nation, Overcharged’ Campaign Aims to Achieve appeared first on MedCity News .

MedCity News · Jun 4, 2026

Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer

Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer appeared first on MedCity News .

MedCity News · Jun 4, 2026

CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery

CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery appeared first on MedCity News .

FDA Recalls · Jun 4, 2026

Ballester Hermanos Realiza un Retiro por Contenido No Declarado de Soya y Leche en Pearl Milling Company Original Pancake & Waffles (MEZCLA PARA PANQUEQUES Y WAFFLES) Complete 5.99oz (170GR) Distribuido en Puerto Rico

Ballester Hermanos está retirando un número limitado de bolsas de 5.99 OZ (170GR) de PEARL MILLING COMPANY ORIGINAL PANCAKE & WAFFLES (MEZCLA PARA PANQUEQUES Y WAFFLES) COMPLETE debido a la presencia no declarada de leche y soya. Las personas con alergia o sensibilidad grave a la leche y/o la soya c

MedTech Dive · Jun 4, 2026

More Americans own wearables, connected health devices: survey

Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from monitoring are less likely to adopt the tools, according to Rock Health.

FDA Recalls · Jun 4, 2026

Ballester Hermanos Issues a Recall Due to Undeclared Soy and Milk in Pearl Milling Company Original Pancake & Waffles (MEZCLA PARA PANQUEQUES Y WAFFLES) Complete 5.99oz (170gr) Distributed in Puerto Rico

Ballester Hermanos is recalling a limited number of 5.99OZ (170GR) pouches of PEARL MILLING COMPANY ORIGINAL PANCAKE & WAFFLES (MEZCLA PARA PANQUEQUES Y WAFFLES) COMPLETE due to undeclared milk and soy. People who have an allergy or severe sensitivity to milk and/or soy run the risk of a serious or

MedCity News · Jun 4, 2026

Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices

MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices appeared first on MedCity News .

BMJ Open · Jun 4, 2026

Polyneuropathy in kidney transplant recipients: a cross-sectional study in Groningen, the Netherlands

Objectives To determine the prevalence and clinical characteristics associated with polyneuropathy in kidney transplant recipients (KTRs). Design Cross-sectional study. Setting SENS study at the University Medical Center Groningen, the Netherlands, December 2021–May 2023. Participants KTR, participating in the ongoing TransplantLines Biobank and Cohort Study, ≥12 months post-transplantation. Main outcome measures Participants underwent a structured neurological assessment including history taking, neurological examination, quantitative sensory testing and nerve conduction studies. An expert…

BMJ Open · Jun 4, 2026

Harms of selected spinal and paraspinal injections and denervation procedures for chronic non-cancer spine pain: a systematic review and meta-analysis of non-randomised studies

Objective To summarise the evidence on long-term and infrequent harms following selected spinal and paraspinal injections and denervation procedures for chronic non-cancer spine pain. Design Systematic review and meta-analysis. Data sources MEDLINE, EMBASE and Cumulative Index to Nursing and Allied Health Literature from inception to October 2023. Study selection Non-randomised studies reporting on harms of selected interventional procedures administered to adults living with chronic axial or radicular non-cancer spine pain with ≥4 weeks of follow-up. Data extraction and synthesis A…

BMJ Open · Jun 4, 2026

Suicides, suicide attempts and suicidal ideation among children and young people exposed to war: a scoping review

Objectives Worldwide, billions of children and young people live in areas affected by war. Suicide remains one of the three leading causes of death worldwide among people aged 15–29 years. However, little is known about the effect of war on suicidal behaviours in this group. This review aims to assess suicides, suicide attempts and suicidal ideation among children and young people exposed to war or armed conflict. Design A scoping review of studies was conducted using Web of Science, PubMed, Embase and PsycINFO databases from their inception to 18 November 2025, without any restrictions on…

BMJ Open · Jun 4, 2026

From victimisation to perpetration: a qualitative exploration of the lived experiences and perceptions of incarcerated women convicted of intimate partner violence in Maputo, Mozambique

Objective Numerous studies focus on women’s experiences of intimate partner violence (IPV), but there is a lack of qualitative studies focusing on women who, as victims, become perpetrators. The study explored the lived experiences and perceptions of incarcerated women convicted of IPV against their partner in Maputo, Mozambique. Design and setting A qualitative approach was utilised with females purposively sampled for one-on-one semi-structured interviews in the Maputo female prison setting. Data were analysed using Interpretive Phenomenological Analysis (IPA). Participants Nine females over…

BMJ Open · Jun 4, 2026

Mapping the current landscape of Klinefelter Syndrome registries: a scoping review

Objectives This scoping review identifies existing registries collecting data on Klinefelter’s syndrome (KS) patients and what data are collected, with the purpose of identifying any KS-specific registries. Findings to be used to inform future registry development. Design A comprehensive scoping review was conducted. Multiple sources were reviewed and articles screened based on inclusion criteria and exclusion criteria. Data sources Searches performed across multiple sources including PubMed, Embase, the Cochrane Library, WHO International Clinical Trials Registry Platform, Orphanet, EU…

← NewerOlder →

Back to the live front page